Author

Xiang-Lin Kong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Sep 2026

Pararectal aggressive angiomyxoma with bilateral ovarian endometriomas cysts: a rare case report

Background Aggressive Angiomyxoma (AAM) is a rare mesenchymal tumor characterized by local invasiveness and a high recurrence rate, often arising in the pelvis and perineum. Case presentation We report a 49-year-old woman presenting with a long-standing pelvic mass. Imaging suggested bilateral ovarian endometriomas and...

Nuo-Wei Ji, Xiang-Lin Kong, Jia-Zhen Huang et al. · Frontiers in Oncology · 0 citations

Clinical trial Open access Aug 2026

Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial

Patients with HER2-positive advanced breast cancer with liver metastases (BCLM) have poor prognosis. Study RC48-C006 is a prospective, open-label, multi-center, randomized phase 2/3 trial (ClinicalTrials.gov identifier, NCT03500380). Based on the phase 2 results, the phase 3 stage was initiated to evaluate disitamab ve...

Jia-Yi Wang, Q. Ouyang, Wei-Min Xie et al. · Nature Communications · 0 citations